Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-640.4%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 2.41Close
$ 2 - $ 2.7 52-Week Range
Ticker Information
Ticker
ORMPCompany Name
ORAMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQORAMED PHARMACEUTICALS INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ORMP - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -12.81M | -640.4% | $ 2M |
| 3/31/2025 | $ -11.41M | -570.75% | $ 2M |
| 12/31/2024 | $ 853K | 0% | $ 0 |
| 9/30/2024 | $ -12.75M | 0% | $ 0 |
| 6/30/2024 | $ -12.36M | 0% | $ 0 |
| 3/31/2024 | $ -862K | -127.89% | $ 674K |
| 12/31/2023 | $ 2.04M | 152.01% | $ 1.34M |
| 9/30/2023 | $ -934K | -46.21% | $ 2.02M |
| 6/30/2023 | $ -2.36M | -87.35% | $ 2.7M |
| 3/31/2023 | $ -233K | -8.62% | $ 2.7M |
Key Performance Insights, Last 5 Years
- ORAMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) Int. Exp. % stands at 16.38%.
- Over the past 5 years, ORAMED PHARMACEUTICALS INC's average Int. Exp. % has been -84.85%.
- The median Int. Exp. % for ORAMED PHARMACEUTICALS INC during this period was -2.74%
- ORAMED PHARMACEUTICALS INC reached its highest Int. Exp. % over the past 5 years at 152.01%.
- The lowest Int. Exp. % recorded by ORAMED PHARMACEUTICALS INC in the same timeframe -640.4%
ORAMED PHARMACEUTICALS INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for ORAMED PHARMACEUTICALS INC is calculated as follows: Int. Exp. [ $ 444K ] / Revenues [ $ 2.71M ]
(=) Int. Exp. % [ 16.38% ] ORMP - Interest Expense Margin, Last 5 years
-640.4%
Minimum
Jun 30, 2025
152.01%
Maximum
Dec 31, 2023
-84.85%
Average
-2.74%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.62% with a standard deviation of 2.19%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.48% |
| average | 1.62% |
| median | 0.79% |
| std | 2.19% |